Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis
PN/PDRN may be useful for scalp repair, hydration, tissue quality and inflammatory balance
SOD1 mutants activate ferroptosis by disrupting metal ion homeostasis, while ferroptosis induces mitochondrial dysfunction, further exacerbating oxidative stress and energy metabolism collapse (Wang L
We believe in the power of simple, effective ingredients
doi: 10.1016/j.biopsycho.2011.02.002 427 HannibalKEBishopMD
Choosing the appropriate condensing agent can enhance reaction efficiency and product purity